Mario Negri - Istituto di Ricerche Farmacologiche

   VERSIONE ITALIANA

The Italian Cochrane Centre (MI)

IFOM

SENDO

 

SENDO

(Southern Europe New Drug Organization)


The Mario Negri Institute is part of SENDO, a non- profit Foundation made up of members of the National Cancer Institute of Milan, the European Oncological Institute of Milan, the Oncological Institute of Italian Switzerland and the Val D’Hebron Hospital of Barcelona. SENDO sets up and verifies, on the pre-clinical and clinical level, development strategies for new anti tumor drugs.

Sendo was was created thanks to the contribution of the Fondazione Italiana per la Ricerca sul Cancro (FIRC) and is supported by the Swiss league, by the Edo Tempia Fund (Biella) and the National Cancer Institute (Bethesda, MD, USA).
It is directed by Doctor Silvia Marsoni.

For additional information visit the website www.sendofoundation.org

 

 
Cerca

PubMed

Staff

Site

Support the research
Cerca

We comply with the HONcode standard for trustworthy health information:
verify here.

 
 

Via La Masa, 19 - 20156 Milano Tel: +39.02.39014.1 Fax: +39.02.354.6277 - +39.02.3900.1918 E-mail: mnegri@marionegri.it
Last update: 8 febbraio 2012 3.16.28 CET